Binding to histone of an anomalous IgG from patients with SLE and drug-induced lupus

Clinical Immunology

Volumn 110, Issue 2, 2004, Pages 145-153

  Teodorescu, M ^a,b   Ustiyan, V ^a   Russo, K ^a,b   Rubin, R L ^c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b TheraTest Laboratories   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Anomalous IgG; Autoantibodies; Histone; Immune complexes; Lupus

Indexed keywords

DNA ANTIBODY; FC RECEPTOR; HISTONE; HISTONE ANTIBODY; IMMUNOGLOBULIN G; PEPSIN A;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLOMERULUS BASEMENT MEMBRANE; HUMAN; INFLAMMATION; LUPUS VULGARIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; SOLID; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANTIGEN-ANTIBODY COMPLEX; CHROMATOGRAPHY, GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTONES; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; NUCLEOSOMES; PEPSIN A;

EID: 1542300945     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2003.11.010     Document Type: Article

References (59)

1. Caulin-Glaser T., Gallo G.R., Lamm M.E. Nondissociating cationic immune complexes can deposit in glomerular basement membrane. J. Exp. Med. 158:1983;1561-1572.
2. Batsford S., Oite T., Takamiya H., Vogt A. Anionic binding sites in the glomerular basement membrane: possible role in the pathogenesis of immune complex glomerulonephritis. Renal Physiol. 3:1980;336-340.
3. Oite T., Shimizu F., Kihara T., Batsford S.R., Vogt A. An active model of immune complex glomerulonephritis in the rat employing cationized antigen. Am. J. Pathol. 112:1983;185-194.
4. Oite T., Batsford S.R., Mihatsch M.J., Takamiya H., Vogt A. Quantitative studies of in situ immune complex glomerulonephritis in the rat induced by planted, cationized antigen. J. Exp. Med. 155:1983;460-474.
5. Lefkowith J.B., Gilkeson G.S. Nephritogenic autoantibodies in lupus: current concepts and continuing controversies. Arthritis Rheum. 39:1996;894-903.
6. Tax W.J., Kramers C., van Bruggen M.C., Berden J.H. Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus. [editorial] Kidney Int. 48:1995;666-673.
7. Rubin R.L. Antihistone antibodies. Lahita R.G. Systemic Lupus Erythematosus. third ed. 1999;227-245 Academic Press, San Diego.
8. Burlingame R.W., Boey M.L., Starkebaum G., Rubin R.L. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J. Clin. Invest. 94:1994;184-192.
9. Schmiedeke T.M., Stockl F.W., Weber R.et al. Histones have high affinity for the glomerular basement membrane. Relevance for immune complex formation in lupus nephritis. J. Exp. Med. 169:1989;1879-1894.
10. Morioka T., Woitas R., Fujigaki Y., Batsford S.R., Vogt A. Histone mediates glomerular deposition of small size DNA anti-DNA complex. Kidney Int. 45:1994;991-997.
11. van Bruggen M.C., Kramers C., Walgreen B.et al. Nucleosomes and histones are present in glomerular deposits in human lupus nephritis. Nephrol. Dial. Transplant. 12:1997;57-66.
12. Bernstein K.A., Di Valerio R., Lefkowith J.B. Glomerular binding activity in MRL lpr serum consists of antibodies that bind to a DNA/Histone/ Type IV collagen complex. J. Immunol. 154:1995;2424-2433.
13. Termaat R.-M., Assmann K.J.M., Dijkman H.B.P.M.et al. Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms. Kidney Int. 42:1992;1363-1371.
14. Amoura Z., Piette J.C., Bach J.F., Koutouzov S. The key role of nucleosomes in lupus. Arthritis Rheum. 42:1999;833-843.
15. Elicha Gussin H.A., Russo K.L., Teodorescu M. The effect of circulating immune complexes on the binding of rheumatoid factor to histones. Ann. Rheum. Dis. 59:2000;351-358.
16. Costa O., Marion C., Monier J.C., Roux B. Non-specific binding of heat-aggregated IgG to histone detected by ELISA. J. Immunol. Methods. 74:1984;283-291.
17. Burlingame R.W., Rubin R.L. Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin. J. Clin. Invest. 88:1991;680-690.
18. Burlingame R.W., Rubin R.L. Autoantibody to the nucleosome subunit (H2A-H2B)-DNA is an early and ubiquitous feature of lupus-like conditions. Mol. Biol. Rep. 23:1996;159-166.
19. Tan E., Cohen A., Fries J.et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25:1982;1271-1279.
20. Ignat G.P., Rat A.C., Sychra J.J.et al. Information on diagnosis and management of systemic lupus erythematosus derived from the routine measurement of 8 nuclear autoantibodies. J. Rheumatol. 30:2003;1761-1769.
21. Elicha Gussin H.A., Tselentis H.N., Teodorescu M. Non cognate binding to histones of IgG from patients with systemic lupus erythematosus. Clin. Immunol. 96:2000;150-161.
22. Totoritis M.C., Tan E.M., McNally E.M., Rubin R.L. Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus. N. Engl. J. Med. 318:1989;1431-1436.
23. Rubin R.L., Burlingame R.W., Arnott J.E.et al. IgG but not other classes of anti-[(H2A-H2B)-DNA] is an early sign of procainamide-induced lupus. J. Immunol. 154:1995;2483-2493.
24. Swedler W., Wallman J., Froelich C.J., Teodorescu M. Routine measurement of IgM, IgG, and IgA rheumatoid factors: high sensitivity, specificity and predictive value for rheumatoid arthritis. J. Rheumatol. 24:1997;1037-1044.
25. Burlingame R.W., Rubin R.L. Subnucleosome structures as substrates in enzyme-linked immunosorbent assays. J. Immunol. Methods. 134:1990;187-199.
26. Fanopoulos D., Teodorescu M.R., Varga J., Teodorescu M. High frequency of abnormal levels of IgA anti-β2 Glycoprotein 1 antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome. J. Rheumatol. 25:1998;675-680.
27. Bustin M., Reisch J., Einck L., Klippel J.H. Autoantibodies to nucleosomal proteins: antibodies to HMG-17 in autoimmune diseases. Science. 215:1982;1245-1247.
28. Gohill J., Cary P., Couppez M., Fritzler M. Antibodies from patients with drug-induced and idiopathic lupus react with epitopes restricted to the amino and carboxy termini of histone. J. Immunol. 135:1985;3116-3121.
29. Hardin J.A., Thomas J.O. Antibodies to histones in systemic lupus erythematosus: localization of prominent autoantigens on histones H1 and H2B. Proc. Natl. Acad. Sci. U.S.A. 80:1983;7410-7414.
30. Costa O., Monier J.C. Antihistone antibodies detected by ELISA and immunoblotting in systemic lupus erythematosus and rheumatoid arthritis. J. Rheumatol. 13:1986;722-725.
31. Konstantinov K., Russanova V., Russeva V. Antibodies to histones and disease activity in systemic lupus erythematosus: a comparative study with an enzyme-linked immunosorbent assay and immunoblotting. Arch. Dermatol. Res. 278:1986;410-415.
32. Hobbs R.N., Clayton A.L., Bernstein R.M. Antibodies to the five histones and poly(adenosine diphosphate-ribose) in drug induced lupus: implications for pathogenesis. Ann. Rheum. Dis. 46:1987;408-416.
33. Shoenfeld Y., Segol G., Segol O.et al. Detection of antibodies to total histones and their subfractions in systemic lupus erythematosus patients and their asymptomatic relatives. Arthritis Rheum. 30:1987;169-175.
34. Muller S., Barakat S., Watts R., Joubaud P., Isenberg D. Longitudinal analysis of antibodies to histones, Sm-D peptides and ubiquitin in the serum of patients with systemic lupus erythematosus, rheumatoid arthritis and tuberculosis. Clin. Exp. Rheumatol. 8:1990;445-453.
35. Bernstein R.M., Hobbs R.N., Lea D.J., Ward D.J., Hughes G.R.V. Pattern of antihistone antibody specificity in systemic rheumatic diseases. Arthritis Rheum. 28:1985;285-293.
36. Shoenfeld Y., Segol O. Anti-histone antibodies in SLE and other autoimmune diseases. Clin. Exp. Rheumatol. 7:1989;265-271.
37. Rubin R.L., Balderas R.S., Tan E.M., Dixon F.J., Theofilopoulos A.N. Multiple autoantigen binding capabilities of mouse monoclonal antibodies selected for rheumatoid factor activity. J. Exp. Med. 159:1984;1429-1440.
38. Andrews B.S., Eisenberg R.A., Theofilopoulos A.N.et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med. 148:1978;1198-1215.
39. Eilat D. Cross-reactions of anti-DNA antibodies and the central dogma of lupus nephritis. Immunol. Today. 6:1985;123-127.
40. Yoshida H., Kohno A., Ohta K.et al. Genetic studies of autoimmunity in New Zealand mice. III. Associations among anti-DNA antibodies, NTA and renal disease in (NZBxNZW)F1 x NZW backcross mice. J. Immunol. 127:1981;433-437.
41. Swanson P.C., Yung R.L., Blatt N.B.et al. Ligand recognition by murine anti-DNA antibodies. II. Genetic analysis and pathogenicity. J. Clin. Invest. 97:1996;1748-1760.
42. Ohnishi K., Ebling F.M., Mitchell B.et al. Comparison of pathogenic and non-pathogenic murine antibodies to DNA: antigen binding and structural characteristics. Int. Immunol. 6:1994;817-830.
43. Maddison P., Reichlin M. Deposition of antibodies to a soluble cytoplasmic antigen in the kidneys of patients with SLE. Arthritis Rheum. 22:1979;858-863.
44. Rumore P., Steinman C. Endogenous circulating DNA in systemic lupus erythematosus-occurrence as multimeric complexes bound to histone. J. Clin. Invest. 86:1990;69-74.
45. Okamura M., Kanayama Y., Amastu K.et al. Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology. Ann. Rheum. Dis. 52:1993;14-20.
46. Suenaga R., Abdou N.I. Anti-(DNA-histone) antibodies in active lupus nephritis. J. Rheumatol. 23:1996;279-284.
47. Kramers C., Hylkema M.N., van Bruggen M.C.J.et al. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J. Clin. Invest. 94:1994;568-577.
48. Richardson B.C., Yung R.L., Johnson K.J., Rowse P.E., Lalwani N.D. Monocyte apoptosis in patients with active lupus. Arthritis Rheum. 39:1996;1432-1434.
49. Ohlenbusch H.H., Olivera B.M., Tuan D., Davidson N. Selective dissociation of histones from calf thymus nucleoprotein. J. Mol. Biol. 25:1967;299-315.
50. Stockl F., Muller S., Batsford S.et al. A role for histones and ubiquitin in lupus nephritis? Clin. Nephrol. 41:1994;10-17.
51. Vogt A., Schmiedeke T., Stockl F.et al. The role of cationic proteins in the pathogenesis of immune complex glomerulonephritis. Nephrol. Dial. Transplant. 5(Suppl. 1):1990;6-9.
52. Monier J.C., Ritter J., Caux C.et al. Canine systemic lupus erythematosus. II. Antinuclear antibodies. Lupus. 1:1992;287-293.
53. Tan C., Pietersz G., Mottram P.et al. Structure, function and transgenic studies identify human Fcγ receptors as early targets for the treatment of autoimmune disease. Tsokos G.C., Sfikakis P.P. Autoimmunity: mechanisms and novel treatments. 2003;38 Aegean Conferences, Myconos, Greece.
54. Herrmann M., Voll R.E., Zoller O.M.et al. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis. Rheum. 41:1998;1241-1250.
55. Amoura Z., Piette J.C., Chabre H.et al. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and clear association with disease activity. Arthritis Rheum. 40:1997;2217-2225.
56. Rubin R.L., Hardtke M.A., Carr R.I. The effect of high antigen density on solid-phase radioimmunoassays for antibody regardless of immunoglobulin class. J. Immunol. Methods. 33:1980;277-292.
57. Bodman-Smith K., Sumar N., Sinclair H.et al. Agalactosyl IgG [Gal(o)] - an analysis of its clinical utility in the long-term follow-up of patients with rheumatoid arthritis. Br. J. Rheumatol. 35:1996;1063-1066.
58. Bodman K.B., Hutchings P.R., Jeddi P.A.et al. IgG glycosylation in autoimmune-prone strains of mice. Clin. Exp. Immunol. 95:1994;103-107.
59. Watson M., Rudd P.M., Bland M., Dwek R.A., Axford J.S. Sugar printing rheumatic diseases. A potential method for disease differentiation using immunoglobulin G oligosaccharides. Arthritis Rheum. 42:1999;1682-1690.